PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells

Sun,Jie; Fu,Shan; Zhong,Weijun; Huang,He

doi:10.3892/or.2013.2786

PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells

Authors:
- Jie Sun
- Shan Fu
- Weijun Zhong
- He Huang
View Affiliations

Affiliations: The First Affiliated Hospital, Medical School of Zhejiang University, Hangzhou 310003, P.R. China
Published online on: October 3, 2013 https://doi.org/10.3892/or.2013.2786
Pages: 2785-2794

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The promyelocytic leukemia (PML) gene, as an important tumor-suppressor, has been proven to regulate stem cell function in multiple tissues; however its role in human mesenchymal stem cells (hMSCs) remains unclear. In the present study, the effect of PML on regulating the proliferation and osteogenic differentiation of hMSCs was explored. New downstream genes that may be responsible for the regulation of PML were found, and possible mechanisms were analyzed. The lentiviral vector which encodes full-length human PML cDNA or shRNA against PML was transfected into hMSCs. RT-PCR and western blotting were used to detect mRNA and protein expression. Flow cytometry was used to analyze apoptosis and the cell cycle distribution. Osteogenic differentiation of hMSCs was induced by osteo-inductive medium for 7 to 14 days. cDNA microarray was used to scan the gene expression profile and to identify significant changes in gene expression. In the present study, we found that PML was stably expressed in hMSCs, and the expression was increased time-dependently along with cell osteogenic differentiation. Overexpression of PML inhibited hMSC proliferation by inducing apoptosis and arresting the cell cycle. However, PML enhanced the osteoblast differentiation potential of hMSCs. PML-overexpressing hMSCs had a significant increase in mineralized matrix production and ALP activity on day 7 under osteogenic or non-osteogenic differentiation conditions. Upregulation of integrin-binding sialoprotein (IBSP, bone sialoprotein) induced by PML overexpression was found. Our data indicate that PML regulates hMSCs as an inhibitor of cell proliferation but a promoter of osteogenic differentiation.

View Figures

View References

1	Chen BY, Wang X, Chen LW and Luo ZJ: Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells. Curr Drug Targets. 13:561–571. 2012. View Article : Google Scholar : PubMed/NCBI
2	Satija NK, Gurudutta GU, Sharma S, et al: Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev. 16:7–23. 2007. View Article : Google Scholar : PubMed/NCBI
3	Ling L, Nurcombe V and Cool SM: Wnt signaling controls the fate of mesenchymal stem cells. Gene. 433:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
4	De Boer J, Wang HJ and Van Blitterswijk C: Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng. 10:393–401. 2004.PubMed/NCBI
5	Shtutman M, Zhurinsky J, Oren M, Levina E and Ben-Ze’ev A: PML is a target gene of β-catenin and plakoglobin, and coactivates β-catenin-mediated transcription. Cancer Res. 62:5947–5954. 2002.
6	Scaglioni PP, Yung TM, Cai LF, et al: A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell. 126:269–283. 2006. View Article : Google Scholar : PubMed/NCBI
7	Regad T, Bellodi C, Nicotera P and Salomoni P: The tumor-suppressor Pml regulates cell fate in the developing neocortex. Nat Neurosci. 12:132–140. 2009. View Article : Google Scholar : PubMed/NCBI
8	Salomoni P, Dvorkina M and Michod D: Role of the promyelocytic leukaemia protein in cell death regulation. Cell Death Dis. 3:e2472012. View Article : Google Scholar : PubMed/NCBI
9	Ito K, Bernardi R, Morotti A, et al: PML targeting eradicates quiescent leukaemia-initiating cells. Nature. 453:1072–1078. 2008. View Article : Google Scholar : PubMed/NCBI
10	Meuleman N, Tondreau T, Delforge A, et al: Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical α-MEM medium. Eur J Haematol. 76:309–316. 2006.PubMed/NCBI
11	Liu L, Yu Q, Lin J, et al: Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev. 20:1961–1971. 2011.
12	Zhang L, Zheng W, Wang Y and Huang H: Human bone marrow mesenchymal stem cells support the derivation and propagation of human induced pluripotent stem cells in culture. Cell Reprogram. 15:216–223. 2013.PubMed/NCBI
13	Gay IC, Chen S and MacDougall M: Isolation and characterization of multipotent human periodontal ligament stem cells. Orthod Craniofac Res. 10:149–160. 2007. View Article : Google Scholar : PubMed/NCBI
14	Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C and Lowe SW: PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14:2015–2027. 2000.
15	Salomoni P, Ferguson BJ, Wyllie AH and Rich T: New insights into the role of PML in tumour suppression. Cell Res. 18:622–640. 2008. View Article : Google Scholar : PubMed/NCBI
16	Wang ZG, Ruggero D, Ronchetti S, et al: PML is essential for multiple apoptotic pathways. Nat Genet. 20:266–272. 1998. View Article : Google Scholar : PubMed/NCBI
17	Li X, Lu Y, Huang W, et al: In vitro effect of adenovirus-mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia. Hematol Oncol. 24:151–158. 2006. View Article : Google Scholar : PubMed/NCBI
18	Lallemand-Breitenbach V and de Thé H: PML nuclear bodies. Cold Spring Harb Perspect Biol. 2:a0006612010. View Article : Google Scholar : PubMed/NCBI
19	Takahashi Y, Lallemand-Breitenbach V, Zhu J and de Thé H: PML nuclear bodies and apoptosis. Oncogene. 23:2819–2824. 2004. View Article : Google Scholar : PubMed/NCBI
20	Conget PA and Minguell JJ: Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 181:67–73. 1999. View Article : Google Scholar : PubMed/NCBI
21	Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
22	George J, Kuboki Y and Miyata T: Differentiation of mesenchymal stem cells into osteoblasts on honeycomb collagen scaffolds. Biotechnol Bioeng. 95:404–411. 2006. View Article : Google Scholar : PubMed/NCBI
23	Ogawa R, Mizuno H, Watanabe A, Migita M, Shimada T and Hyakusoku H: Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice. Biochem Biophys Res Commun. 313:871–877. 2004. View Article : Google Scholar : PubMed/NCBI
24	Keselowsky BG, Collard DM and García AJ: Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci USA. 102:5953–5957. 2005. View Article : Google Scholar : PubMed/NCBI
25	Ilmer M, Karow M, Geissler C, Jochum M and Neth P: Human osteoblast-derived factors induce early osteogenic markers in human mesenchymal stem cells. Tissue Eng Part A. 15:2397–2409. 2009. View Article : Google Scholar : PubMed/NCBI
26	Shimizu E, Matsuda-Honjyo Y, Samoto H, et al: Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif. J Cell Biochem. 91:1183–1196. 2004. View Article : Google Scholar
27	Zhang X, Odom DT, Koo SH, et al: Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA. 102:4459–4464. 2005. View Article : Google Scholar : PubMed/NCBI
28	Doucas V: The promyelocytic (PML) nuclear compartment and transcription control. Biochem Pharmacol. 60:1197–1201. 2000. View Article : Google Scholar : PubMed/NCBI
29	Marie PJ: Fibroblast growth factor signaling controlling bone formation: an update. Gene. 498:1–4. 2012. View Article : Google Scholar : PubMed/NCBI
30	Ryu E, Hong S, Kang J, et al: Identification of senescence-associated genes in human bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 371:431–436. 2008. View Article : Google Scholar : PubMed/NCBI
31	Coutu DL, François M and Galipeau J: Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood. 117:6801–6812. 2011. View Article : Google Scholar : PubMed/NCBI